Date & Time
Tuesday, April 12, 2022, 1:15 PM - 2:30 PM
Name
141 Medication-Assisted Treatment Protocol for Long-Acting Buprenorphine Formulations*
Description

This presentation describes a protocol for transitioning to buprenorphine for maintenance treatment of a patient's problem opioid use. Long-acting formulations of buprenorphine may provide advantages over sublingual buprenorphine products. One advantage is that improved compliance should lead to more consistent blood levels and therefore greater effectiveness in preventing relapse. Long-acting formulations also should provide significant protection against misuse and diversion.

Educational Objectives

  • Review protocols for transitioning patients with opioid use disorder to long-acting buprenorphine formulations
  • Describe how to monitor safe use of long-acting buprenorphine formulations
  • Summarize federal regulations on use of buprenorphine for maintenance treatment

Level: Advanced